Articles On Creso Pharma (ASX:CPH)

–The below is a company-sponsored announcement– Australia’s cannabis stocks have reacted positively to news of the Therapeutic Goods Administration (TGA) interim decision to paves the way for over the counter cannabidiol (CBD) sales witho...

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

Special Report: Creso Pharma smells opportunity after Australian regulators moved to make CBD oil products available without a prescription. Hemp and cannabis company Creso Pharma (ASX:CPH) has plans to pursue a number of initiatives in the...

Creso Pharma Limited (ASX:CPH, FRA: 1X8) is one of several cannabis stocks to respond positively today to what is considered to be a major announcement by the Therapeutic Goods Administration (TGA). The TGA has announced its interim decisio...

The decision to down schedule cannabidiol products to schedule 3 medicine would allow Australian consumers to purchase CBD products following consultation with a pharmacist without the need for a prescription.

Creso Pharma Limited (ASX: CPH, FRA: 1X8) has welcomed yesterday's interim decision from the Therapeutic Goods Administration (TGA) regarding the sale of cannabidiol (CBD) over the counter in pharmacies. As reported yesterday, the TGA's d...

Creso Pharma Limited (ASX: CPH, FRA: 1X8) has welcomed yesterday's interim decision from the Therapeutic Goods Administration (TGA) regarding the sale of cannabidiol (CBD) over the counter in pharmacies. As reported yesterday, the TGA's d...

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses the ‘hidden gem’ animal health market. Populating the expert panel this week...

Along with board changes, the CEO will transition to a technology, innovation and distribution role to drive near-term commercialisation opportunities in Europe and Canada.

The companies are working on introducing the products in Spain and Portugal in the first quarter of 2021.

Creso Pharma Limited (ASX:CPH; FRA: 1X8) has signed a commercial agreement with DHS Business Portugal to introduce the group’s products into the Portuguese and Spanish markets, effectively expanding the company’s presence in Europe. DHS has...

A quick wrap of the ASX’s key winners and losers on Tuesday, August 11. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 675 stocks rose, 673 declined and...

Mernova Medicinal Ltd, a wholly-owned subsidiary of Creso Pharma Limited (ASX:CPH), has received a US$625,000 (AUD$901,000) purchase order for its premium, cured and hand-trimmed dried medicinal cannabis flower. The order from Univo Pharm...

Creso Pharma Limited’s (ASX:CPH;FRA:1X8) wholly-owned subsidiary Mernova Medicinal Ltd has received a US$625,000 purchase order for its premium, cured and hand-trimmed dried medicinal cannabis flower from Univo Pharmaceuticals Ltd (TLV: UNV...

Special Report: Medical cannabis company Creso Pharma has been winning customers around the world and has built on its bridgehead in Israel with a second customer order. Creso Pharma (ASX:CPH) has picked up another customer order for its pr...

The order valued at US$625,000 from Univo Pharmaceuticals will allow Creso to leverage Univo’s extensive distribution networks into the rapidly growing Israeli market.

In June, ASX-listed companies of all sizes continued to raise capital but the small-cap sector was particularly busy. Stocks with market capitalisations of under $100m at the time of the deal raised $274m in the last month. This is triple M...

Mernova Medicinal is scaling up cannabis production towards maximum capacity to meet growing demand from medical and recreational markets in Canada.

Special Report: Creso Pharma’s Canadian growing facility is gearing up for launch.   Creso Pharma’s (ASX:CPH) Canadian medical cannabis cultivation subsidiary Mernova has streamlined operations as it ramps up production ahead of the launch...

Mernova Medicinal Inc is scaling up cannabis production towards maximum capacity to meet growing demand from medical and recreational markets in Canada.

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

A joint statement issued by government parties on June 9 detailed steps towards easing cannabis restrictions on recreational and medical use.

Special Report: Medical cannabis stock Creso is set to start selling products in Canada.   Creso Pharma (ASX:CPH) says its Canadian subsidiary Mernova Medicinal Inc will soon be able to offer high quality cannabis products to the retail rec...

Mernova will begin selling its dried and fresh cannabis products under the sales licence to provincially and territorially authorised retailers for medical purposes.

Special Report: Creso Pharma’s South African partner has launched cannaQIX®Regular under the brand name Cannamics. Creso Pharma (ASX:CPH) is now selling in South Africa, after commercial partner Pharma Dynamics successfully launched cannaQI...

Creso is progressing its strategy to commercialise the CannaQIX® range, which is among its CBD products.

Special Report: The company’s distribution network will give it access to over 4,200 points of sale across three of Brazil’s major metro areas – for an estimated target market of 14 million consumers. For medicinal cannabis company Creso Ph...

DHS specialises in healthcare markets and commercialisation initiatives and has a solid base of established in-country networks and operations in the US, Africa and Portugal as well as Brazil.

Creso’s Canadian subsidiary Mernova Medical has started generating revenue and is in advanced stages of securing EU GMP certification.

North American pot stocks are roaring back from lows in March but the same cannot be said for their antipodean counterparts, many of which continue to wallow. The New Cannabis Ventures Global Cannabis Stock Index soared 26 per cent last wee...

Special Report: The agreement offers a significant opportunity for Creso, in a big market with strong potential demand for innovative health products. The coronavirus pandemic has created challenging conditions for many companies globally....

Special Report: Creso Pharma has delivered a large shipment of animal health product anibidiol to its multinational partner Virbac, making significant revenue in the process.   Creso Pharma (ASX:CPH) has delivered a large shipment of anibid...

Creso Pharma Limited (ASX: CPH) is expanding its available product line with the release of a hemp tea in Q3 2020.

The $9.9 million capped Australian-listed Creso Pharma Limited (ASX:CPH) is set to release CBD hemp teas in Q3 2020. Creso is looking to expand its footprint in the health and wellness cannabis sector, with the market on track to grow to US...

As retailers in Australia, struggle to keep up with the demands of panic buying due to the Coronavirus (COVID-19), around the world non-essential retailers are now being forced to close down. This includes legal cannabis dispensaries in cou...

Special Report: As Creso hires two top guns to lead its Canadian operation, it has also ramped up production and received a $C410,000 order. Two former Canopy Growth executives have joined Creso Pharma’s (ASX:CPH) senior leadership team at...

–The below is  a company sponsored announcement– Creso Pharma Limited ((CPH)) has appointed two former Canopy Growth Corp. (TSX:WEED, NYSE:CGC) executives to the senior management team of its wholly-owned Mernova Medical Inc. in Nova Scot...

ASX Junior Creso Pharma (ASX: CPH) has appointed two former Canopy executives to the senior management team of its wholly-owned Mernova Medical Inc. in Nova Scotia, Canada.

Creso Pharma Limited (ASX:CPH) has appointed two executives to the senior management team of its wholly-owned Mernova Medical Inc. in Nova Scotia, Canada. Jack Yu has been appointed Managing Director and Isaac Allen has been appointed Vice...

Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.

The following article is sponsored content in partnership with Finfeed. Business News Australia does not give financial advice. Cannabis has a place in global economies, but it seems the companies that will survive will be the ones who ha...

The following article is sponsored content in partnership with Finfeed. Business News Australia does not give financial advice. Cannabis has a place in global economies, but it seems the companies that will survive will be the ones who ha...

–The below is a company sponsored announcement– Cannabis has a place in global economies, but it seems the companies that will survive will be the ones who have a solid product offering that benefits consumers and therefore has a positive...

There are ASX small caps addressing brain problems and stocks seeking to test cannabis for medicinal purposes and Impression Healthcare (ASX:IHL) is now doing both. This morning the company announced next quarter it would begin a clinical t...

Creso Pharma Limited (ASX:CPH) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products. Farmagon is an established wholesale distributor in Norway, with over 25 years of e...

From soup to oils, supplements and powders, hemp is a seriously versatile product and consumers are hungry for its beneficial properties. But for Australian cannabis companies the plant presents a wealth of opportunity to generate cash co...

Creso Pharma (ASX:CPH) today announced the successful development of anibidiol®EQUI, a flavoured micromilled hemp plant product for equines and large animals.

It has been a highly productive start to the year for Creso Pharma Limited (ASX:CPH, FRA:1X8), but the company isn’t prepared to rest on its laurels and is already thinking about product launches in the second half of 2020. One of the new p...